Checkpoint Therapeutics Stock Options
| CKPT Stock | USD 2.86 0.15 5.54% |
Checkpoint Therapeutics' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 2.43 with a put-to-call open interest ratio of 0.23 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
Checkpoint Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Checkpoint Therapeutics' lending market. For example, when Checkpoint Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Checkpoint Therapeutics, he or she must hedge the risk by shorting Checkpoint Therapeutics stock over its option's life.
2025-04-17
The chart above shows Checkpoint Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Checkpoint Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Checkpoint Therapeutics' option, there is no secondary market available for investors to trade.
Checkpoint Therapeutics Maximum Pain Price Across 2025-04-17 Option Contracts
Max pain occurs when Checkpoint Therapeutics' market makers reach a net positive position across all Checkpoint Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Checkpoint Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Checkpoint Therapeutics
Analyzing Checkpoint Therapeutics' in-the-money options over time can help investors to take a profitable long position in Checkpoint Therapeutics regardless of its overall volatility. This is especially true when Checkpoint Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Checkpoint Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Checkpoint Therapeutics' stock while costing only a fraction of its price.
Checkpoint Therapeutics In The Money Call Balance
When Checkpoint Therapeutics' strike price is surpassing the current stock price, the option contract against Checkpoint Therapeutics stock is said to be in the money. When it comes to buying Checkpoint Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Checkpoint Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Checkpoint Current Options Market Mood
Checkpoint Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Checkpoint Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Checkpoint Therapeutics' options investors are not very successful. Checkpoint Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Checkpoint contract
Base on the Rule 16, the options market is currently suggesting that Checkpoint Therapeutics will have an average daily up or down price movement of about 0.15% per day over the life of the 2025-04-17 option contract. With Checkpoint Therapeutics trading at USD 2.86, that is roughly USD 0.004344. If you think that the market is fully incorporating Checkpoint Therapeutics' daily price movement you should consider buying Checkpoint Therapeutics options at the current volatility level of 2.43%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Checkpoint |
Purchasing Checkpoint Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Checkpoint calls. Remember, the seller must deliver Checkpoint Therapeutics stock to the call owner when a call is exercised.
Checkpoint Therapeutics Option Chain
When Checkpoint Therapeutics' strike price is surpassing the current stock price, the option contract against Checkpoint Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Checkpoint Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Checkpoint. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Checkpoint. It also shows strike prices and maturity days for a Checkpoint Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CKPT250417C00002500 | 1379 | 2.5 | 0.55 - 0.85 | 0.75 | In |
Call | CKPT250417C00005000 | 5395 | 5.0 | 0.15 - 0.25 | 0.25 | Out |
Call | CKPT250417C00007500 | 503 | 7.5 | 0.0 - 0.25 | 0.06 | Out |
Put | CKPT250417P00002500 | 1386 | 2.5 | 0.05 - 3.2 | 0.5 | Out |
Put | CKPT250417P00005000 | 294 | 5.0 | 0.35 - 4.9 | 1.95 | In |
Put | CKPT250417P00007500 | 7 | 7.5 | 2.3 - 7.0 | 4.4 | In |
Checkpoint Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Checkpoint Total Stockholder Equity
Total Stockholder Equity |
|
Checkpoint Therapeutics Corporate Executives
Elected by the shareholders, the Checkpoint Therapeutics' board of directors comprises two types of representatives: Checkpoint Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Checkpoint. The board's role is to monitor Checkpoint Therapeutics' management team and ensure that shareholders' interests are well served. Checkpoint Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Checkpoint Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Gray | Corporate CFO | Profile | |
| William CPA | Corporate CFO | Profile |
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.